| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |